JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Activity Details

228 * ! Mon, 7/30/2012, 2:00 PM - 3:50 PM CC-Room 29C
Implementing Bayesian Methods in Drug Development — Topic Contributed Papers
Section on Bayesian Statistical Science , Biopharmaceutical Section , Biometrics Section
Organizer(s): Fanni Natanegara, Eli Lilly and Company
Chair(s): Fanni Natanegara, Eli Lilly and Company
2:05 PM Use of Bayesian Methods to Assess Probability of Achieving Critical Success Factors (CSFs) in Clinical Trials Cory Heilmann, Eli Lilly and Company
2:25 PM Bayesian Implementations in Drug Development: Why Progress Is Slow Beat Neuenschwander, Novartis Pharma
2:45 PM Implementing Bayesian Methods in Biological Product Development: Regulatory Perspective and Experience Boguang Zhen, FDA/CBER
3:05 PM Discussant: John W. Seaman, PhD, Baylor University
3:25 PM Discussant: Heinz Schmidli, Novartis Pharma AG
3:45 PM Floor Discussion

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.